SIT Pharma was mentioned by the prestigious business publication “Il Sole 24 Ore” in its 18 April 2025 edition, in a space dedicated to outstanding companies in the Pavia area.
SIT PHARMA is pleased to announce the acquisition of OSTIDIL-D3 and KEFORAL
SIT Pharma is pleased to announce the acquisition of DERINOX® from Therabel Lucien Pharma Sas
SIT Pharma is pleased to announce the acquisition of MIZOLLEN® from THERABEL HEALTHCARE LIMITED